- NEWS
Latest results put Oxford–AstraZeneca COVID vaccine back on track
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-00836-z
What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine
Oxford COVID-vaccine paper highlights lingering unknowns about results
Why COVID vaccines are so difficult to compare
Rare COVID reactions might hold key to variant-proof vaccines